Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
4,447,052
-
Share change
-
+821,745
-
Total reported value
-
$6,425,387
-
Put/Call ratio
-
80%
-
Price per share
-
$1.44
-
Number of holders
-
49
-
Value change
-
+$1,136,322
-
Number of buys
-
26
-
Number of sells
-
16
Institutional Holders of Fortress Biotech, Inc. - COM NEW (FBIO) as of Q3 2024
As of 30 Sep 2024 Fortress Biotech, Inc. - COM NEW (FBIO) had 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,447,052 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, Cambridge Investment Research Advisors, Inc., Rosalind Advisors, Inc., ACADIAN ASSET MANAGEMENT LLC, PVG ASSET MANAGEMENT CORP, SHIKIAR ASSET MANAGEMENT INC, ENVESTNET ASSET MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, Nantahala Capital Management, LLC, and BlackRock, Inc..
This table shows 49 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.